Ischemic Attack, Transient: Clinical Trials

4 trials for Ischemic Attack, Transient, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Ischemic Attack, Transient: new trials by email Literature Review of Ischemic Attack, Transient trials Research Report on Ischemic Attack, Transient

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimal Blood Pressure and Cholesterol Targets for Preventing Recurrent Stroke in Hypertensives
all approved antihypertensive drugs; all approved statins - Stroke, Transient Ischemic Attack
Phase 4CompletedIstituto Auxologico Italiano2002013-04-012024-02-20
Efficacy and Cost-Effectiveness of Cost-free Pharmacotherapy for Smoking Cessation for High-risk Smokers With Cerebrovascular Disease
Cost-Free Pharmacotherapy Group, Prescription Only Group - Cerebrovascular Disorders, Smoking Cessation
Phase 4CompletedOttawa Heart Institute Research Corporation1942009-12-012026-08-10
Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
Antihypertensive agents and lipid lowering therapy, Usual Care - Ischemic Stroke, Transient Ischemic Attacks
Phase 4CompletedUniversity of Alberta2792009-01-012018-10-15
ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
anticoagulation, aspirin and dipyridamole, aspirin alone - Brain Ischemia, Transient Ischemic Attack
Phase 4CompletedUMC Utrecht45001997-07-012007-03-22

Narrower conditions

Stroke (3)  ·  Arteriosclerosis (1)  ·  Brain Ischemia (1)  ·  Cerebrovascular Disorders (1)  ·  Dementia (1)  ·  Heart Failure (1)  ·  Hypertension (1)  ·  Ischemic Stroke (1)  ·  Myocardial Infarction (1)  ·  Smoking Cessation (1)

Broader conditions

Brain Diseases (4)  ·  Cardiovascular Diseases (4)  ·  Central Nervous System Diseases (4)  ·  Nervous System Diseases (4)  ·  Vascular Diseases (4)  ·  Brain Ischemia (3)  ·  Cerebrovascular Disorders (3)  ·  Arterial Occlusive Diseases (1)  ·  Behavior (1)  ·  Health Behavior (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Mental Disorders (1)  ·  Myocardial Ischemia (1)

Interventions

Adrenergic alpha-Antagonists (1)  ·  Adrenergic beta-Antagonists (1)  ·  Angiotensin Receptor Antagonists (1)  ·  Angiotensin-Converting Enzyme Inhibitors (1)  ·  Antihypertensive Agents (1)  ·  Aspirin (1)  ·  Atorvastatin (1)  ·  Bupropion (1)  ·  Calcium Channel Blockers (1)  ·  Dipyridamole (1)  ·  Fluvastatin (1)  ·  Mineralocorticoid Receptor Antagonists (1)  ·  Pravastatin (1)  ·  Rosuvastatin Calcium (1)  ·  Simvastatin (1)

Sponsors

Istituto Auxologico Italiano (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  UMC Utrecht (1)  ·  University of Alberta (1)

Countries

Canada (2)  ·  Netherlands (1)  ·  Russia (1)

Top investigators

A. Algra, Professor (1)  ·  Alberto Zanchetti (1)  ·  Andrew Pipe, MD (1)  ·  Debbie Aitken, RN BScN (1)  ·  Finlay A McAlister, MD, MSc (1)  ·  Grant Stotts, MD (1)  ·  J. Gijn Van, Professor (1)  ·  Kerri-Anne Mullen, MSc (1)  ·  Lisheng Liu, MD (1)  ·  Mary Ann Laplante, RN BScN (1)  ·  Robert Reid, MBA PhD (1)  ·  Sophia Gocan, RN BScN (1)  ·  Sophia Papadakis, MHA (1)

Results publications

PMID 16714187, PMID 17239798, PMID 21330625, PMID 24733770, PMID 24979303, PMID 25458657, PMID 32905623, PMID 36398903